Article Information
- Received October 23, 2015
- Revision received February 26, 2016
- Accepted March 31, 2016
- First published May 11, 2016.
- Version of record published May 11, 2016.
Author Information
- Tal Iram1,2,3,
- Zaida Ramirez-Ortiz1,
- Michael H. Byrne1,
- Uwanda A. Coleman1,
- Nathan D. Kingery1,
- Terry K. Means1,
- Dan Frenkel2,3, and
- Joseph El Khoury1,4
- 1Center for Immunology and Inflammatory Diseases and Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114,
- 2Sagol School of Neuroscience and
- 3Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel 69978, and
- 4Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114
Author contributions
Author contributions: T.I., T.K.M., D.F., and J.E.K. designed research; T.I., M.H.B., U.A.C., and N.D.K. performed research; Z.R.-O. contributed unpublished reagents/analytic tools; T.I., Z.R.-O., N.D.K., T.K.M., D.F., and J.E.K. analyzed data; T.I., D.F., and J.E.K. wrote the paper.
Disclosures
- Received October 23, 2015.
- Revision received February 26, 2016.
- Accepted March 31, 2016.
This work is supported by National Institutes of Health Grants U24 AI082660 (J.E.K.) and R01-AI084884 (T.K.M.), Alzheimer's Association Grant NIRG-11-205535, and a grant from the Ministry of Science, Technology, and Space (D.F.). During this research, T.I. received a student fellowship from the Israeli National Network of Excellence in Neuroscience funded by Teva Pharmaceutical Industries and a student fellowship from the Clore Israel Foundation. We thank Prof. Zvi Fishelson (Tel Aviv University, Tel Aviv, Israel) for critical reading of the manuscript.
- Correspondence should be addressed to Joseph El Khoury, Division of Infectious Diseases, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114. jelkhoury{at}mgh.harvard.edu
